SEC Form 4 · accession 0001055726-19-000015

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Jong Joseph Kim

Officer — Chief Executive Officer · Director

Period of report

Mar 8, 2019

Accepted (ET)

Mar 12, 2019 · 5:08 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001055726

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 9, 2019	M	57,333	—	A	2,451,788	D
Common Stock	Mar 9, 2019	F	16,329	$3.34	D	2,435,459	D
Common Stock^F3	Mar 10, 2019	M	105,700	—	A	2,541,159	D
Common Stock	Mar 10, 2019	F	30,104	$3.34	D	2,511,055	D
Common Stock	holding	—	—		—	1,750,000	I	By Family Limited Partnership
Common Stock	holding	—	—		—	33,563	I	By Daughter: EK
Common Stock	holding	—	—		—	33,775	I	By Son: JK1
Common Stock	holding	—	—		—	5,975	I	By Spouse
Common Stock	holding	—	—		—	33,533	I	By Son: JK2

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F1	—	Mar 9, 2019	M	57,333	D	—	—	Common Stock	57,333	0	D
Restricted Stock Unit^F3	—	Mar 10, 2019	M	105,700	D	—	—	Common Stock	105,700	105,700	D
Common Stock Option^F5	$3.34	Mar 8, 2019	A	298,100	A	Mar 8, 2019	Mar 8, 2029	Common Stock	298,100	298,100	D
Restricted Stock Unit^F6	—	Mar 8, 2019	A	191,100	A	—	—	Common Stock	191,100	191,100	D

Explanation of responses

F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 172,000 restricted stock units was as follows: 57,334 shares vested on March 9, 2017; 57,333 shares vested on March 9, 2018; 57,333 shares vested on March 9, 2019.
F2The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units award reported in footnote (1) herein.
F3Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 317,100 restricted stock units is as follows: 105,700 shares vested on March 10, 2018; 105,700 shares vested on March 10, 2019; 105,700 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units award reported in footnote (3) herein.
F5The vesting schedule for the 298,100 options is as follows: 74,525 shares vested on March 8, 2019; 74,525 shares will vest on March 8, 2020; 74,525 shares will vest on March 8, 2021; 74,525 shares will vest on March 8, 2022.
F6Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares will vest on March 8, 2020; 63,700 shares will vest on March 8, 2021; 63,700 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.